title: Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial.
authors.affiliation: Oncology Unit, Laennec Hospital, Paris, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Tourani
authors.forename: P
authors.initials: P
authors.lastname: Grise
authors.forename: V
authors.initials: V
authors.lastname: Lucas
authors.forename: D
authors.initials: D
authors.lastname: Mayeur
authors.forename: B
authors.initials: B
authors.lastname: Dufour
authors.forename: M
authors.initials: M
authors.lastname: Di Palma
authors.forename: C
authors.initials: C
authors.lastname: Boaziz
authors.forename: J M
authors.initials: JM
authors.lastname: Pavlovitch
authors.forename: E
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.forename: D
authors.initials: D
authors.lastname: Larregain
authors.forename: M
authors.initials: M
authors.lastname: Untereiner
mesh_terms: D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins